Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology Details strong pipeline including ...
Management did not provide specific revenue or EPS guidance for the second half of 2025 but Traverse stated, "We continue to be the second half of 2025 as an important period of progress for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results